Search Results - "HALE, Gregory"

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors by HAHN, Theresa, MCCARTHY, Philip L, LOBERIZA, Fausto, MAZIARZ, Richard T, RIZZO, J. Douglas, JOFFE, Steven, PARSONS, Susan, MAJHAIL, Navneet S, HASSEBROEK, Anna, BREDESON, Christopher, GAJEWSKI, James L, HALE, Gregory A, ISOLA, Luis M, LAZARUS, Hillard M, LEE, Stephanie J, LEMAISTRE, Charles F

“…Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases…”
Get full text

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients by Heslop, Helen E., Slobod, Karen S., Pule, Martin A., Hale, Gregory A., Rousseau, Alexandra, Smith, Colton A., Bollard, Catherine M., Liu, Hao, Wu, Meng-Fen, Rochester, Richard J., Amrolia, Persis J., Hurwitz, Julia L., Brenner, Malcolm K., Rooney, Cliona M.

“…T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)–stimulated immunity has the potential to fill an important niche in targeted therapy for…”
Get full text

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma by SMITH, Sonali M, BURNS, Linda J, HOLMBERG, Leona A, SUREDA, Anna, FREYTES, Cesar O, MAZIARZ, Richard Thomas, INWARDS, David J, GALE, Robert Peter, GROSS, Thomas G, CAIRO, Mitchell S, COSTA, Luciano J, LAZARUS, Hillard M, VAN BESIEN, Koen, WIERNIK, Peter H, MAHARAJ, Dipnarine, LAPORT, Ginna G, MONTOTO, Silvia, HARI, Parameswaran N, LERADEMACHER, Jennifer, WENSHENG HE, FENSKE, Timothy S, SUZUKI, Ritsuro, HSU, Jack W, SCHOUTEN, Harry C, HALE, Gregory A

“…To analyze outcomes of hematopoietic cell transplantation (HCT) in T-cell non-Hodgkin lymphoma. Outcomes of 241 patients (112 anaplastic large-cell lymphoma,…”
Get full text

Neural ensemble communities: open-source approaches to hardware for large-scale electrophysiology by Siegle, Joshua H, Hale, Gregory J, Newman, Jonathan P, Voigts, Jakob

“…Highlights • Large-scale electrophysiology is a method that could benefit from open hardware. • The resources for designing and building open tools have…”
Get full text

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders by Horan, John, Wang, Tao, Haagenson, Michael, Spellman, Stephen R., Dehn, Jason, Eapen, Mary, Frangoul, Haydar, Gupta, Vikas, Hale, Gregory A., Hurley, Carolyn K., Marino, Susana, Oudshoorn, Machteld, Reddy, Vijay, Shaw, Peter, Lee, Stephanie J., Woolfrey, Ann

“…The importance of human leukocyte antigen (HLA) matching in unrelated donor transplantation for nonmalignant diseases (NMD) has yet to be defined. We analyzed…”
Get full text

Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis by Amankwah, Ernest K., Saenz, Ashleigh M., Hale, Gregory A., Brown, Patrick A.

“…Obesity is a risk factor for mortality and relapse of certain cancers. However, existing evidence for pediatric leukemia is inconsistent. The aim of this…”
Get full text

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial by Gajjar, Amar, Chintagumpala, Murali, Ashley, David, Kellie, Stewart, Kun, Larry E, Merchant, Thomas E, Woo, Shaio, Wheeler, Greg, Ahern, Valerie, Krasin, Matthew J, Fouladi, Maryam, Broniscer, Alberto, Krance, Robert, Hale, Gregory A, Stewart, Clinton F, Dauser, Robert, Sanford, Robert A, Fuller, Christine, Lau, Ching, Boyett, James M, Wallace, Dana, Gilbertson, Richard J

“…Current treatment for medulloblastoma, which includes postoperative radiotherapy and 1 year of chemotherapy, does not cure many children with high-risk…”
Get more information

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made? by HORAN, John T, LOGAN, Brent R, KHOURY, Hanna Jean, JUCKETT, Mark B, LITZOW, Mark R, MARTINO, Rodrigo, MCCARTHY, Philip L, SMITH, Franklin O, RIZZO, J. Douglas, PASQUINI, Marcelo C, AGOVI-JOHNSON, Manza-A, LAZARUS, Hillard M, BACIGALUPO, Andrea A, BALLEN, Karen K, BREDESON, Christopher N, CARABASI, Matthew H, GUPTA, Vikas, HALE, Gregory A

“…Transplantation-related mortality (TRM) is a major barrier to the success of allogeneic hematopoietic cell transplantation (HCT). We assessed changes in the…”
Get full text

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI by Copelan, Edward A., Hamilton, Betty K., Avalos, Belinda, Ahn, Kwang Woo, Bolwell, Brian J., Zhu, Xiaochun, Aljurf, Mahmoud, van Besien, Koen, Bredeson, Christopher, Cahn, Jean-Yves, Costa, Luciano J., de Lima, Marcos, Gale, Robert Peter, Hale, Gregory A., Halter, Joerg, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Litzow, Mark R., Loren, Alison W., Marks, David I., Olavarria, Eduardo, Roy, Vivek, Sabloff, Mitchell, Savani, Bipin N., Seftel, Matthew, Schouten, Harry C., Ustun, Celalettin, Waller, Edmund K., Weisdorf, Daniel J., Wirk, Baldeep, Horowitz, Mary M., Arora, Mukta, Szer, Jeff, Cortes, Jorge, Kalaycio, Matt E., Maziarz, Richard T., Saber, Wael

“…Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the most widely used myeloablative conditioning regimens for…”
Get full text

A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia by Hale, Victoria, Hale, Gregory A, Brown, Patrick A, Amankwah, Ernest K

“…Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial…”
Get more information

The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2 by Riley, Lisa G, Heeney, Matthew M, Rudinger-Thirion, Joëlle, Frugier, Magali, Campagna, Dean R, Zhou, Ronghao, Hale, Gregory A, Hilliard, Lee M, Kaplan, Joel A, Kwiatkowski, Janet L, Sieff, Colin A, Steensma, David P, Rennings, Alexander J, Simons, Annet, Schaap, Nicolaas, Roodenburg, Richard J, Kleefstra, Tjitske, Arenillas, Leonor, Fita-Torró, Josep, Ahmed, Rasha, Abboud, Miguel, Bechara, Elie, Farah, Roula, Tamminga, Rienk Yj, Bottomley, Sylvia S, Sanchez, Mayka, Swinkels, Dorine W, Christodoulou, John, Fleming, Mark D

“…YARS2 variants have previously been described in patients with myopathy, lactic acidosis and sideroblastic anemia 2 (MLASA2). YARS2 encodes the mitochondrial…”
Get full text

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG‐asparaginase, and doxorubicin by Trucco, Matteo, Barredo, Julio C., Goldberg, John, Leclerc, Gilles M., Hale, Gregory A., Gill, Jonathan, Setty, Bhuvana, Smith, Tiffany, Lush, Richard, Lee, Jae K., Reed, Damon R.

“…Background Acute lymphoblastic leukemia (ALL) remains a major cause of death in children. AMP‐activated protein kinase (AMPK) affects the unfolded protein…”
Get full text

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors by GUPTA, Vikas, EAPEN, Mary, SABLOFF, Mitchell, SCHREZENMEIER, Hubert, SOCIE, Gerard, MARSH, Judith C. W, BRAZAUSKAS, Ruta, CARRERAS, Jeanette, ALJURF, Mahmoud, GALE, Robert Peter, HALE, Gregory A, ILHAN, Osman, PASSWEG, Jakob R, RINGDEN, Ollé

“…Transplantation from an HLA-matched sibling is the treatment of choice for young patients with acquired severe aplastic anemia. For older patients, the…”
Get full text

HLA-matched sibling bone marrow transplantation for β-thalassemia major by Sabloff, Mitchell, Chandy, Mammen, Wang, Zhiwei, Logan, Brent R., Ghavamzadeh, Ardeshir, Li, Chi-Kong, Irfan, Syed Mohammad, Bredeson, Christopher N., Cowan, Morton J., Gale, Robert Peter, Hale, Gregory A., Horan, John, Hongeng, Suradej, Eapen, Mary, Walters, Mark C.

“…We describe outcomes after human leukocyte antigen-matched sibling bone marrow transplantation (BMT) for 179 patients with β-thalassemia major. The median age…”
Get full text

Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia by HAHN, Theresa, MCCARTHY, Philip L, MAZIARZ, Richard T, VAN ROOD, Jon J, GUPTA, Vikas, HALTER, Joerg, REDDY, Vijay, TIBERGHIEN, Pierre, LITZOW, Mark, ANASETTI, Claudio, PAVLETIC, Stephen, RINGDEN, Olle, ZHANG, Mei-Jie, DAN WANG, ARORA, Mukta, FRANGOUL, Haydar, GALE, Robert Peter, HALE, Gregory A, HORAN, John, ISOLA, Luis

“…Acute graft-versus-host disease (GVHD) causes substantial morbidity and mortality after human leukocyte antigen (HLA)-identical sibling transplants. No large…”
Get full text

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia by Vrooman, Lynda M., Kirov, Ivan I., Dreyer, ZoAnn E., Kelly, Michael, Hijiya, Nobuko, Brown, Patrick, Drachtman, Richard A., Messinger, Yoav H., Ritchey, A. Kim, Hale, Gregory A., Maloney, Kelly, Lu, Yuan, Plourde, Paul V., Silverman, Lewis B.

“…Background Erwinia asparaginase is antigenically distinct from E.coli‐derived asparaginase and may be used after E.coli‐derived asparaginase hypersensitivity…”
Get full text

Amifostine Protects Against Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma by FOULADI, Maryam, CHINTAGUMPALA, Murali, HALE, Gregory A, KASOW, Kimberly A, MERCHANT, Thomas E, MORRIS, Brannon, KRASIN, Matthew, KUN, Larry E, BOYETT, James M, GAJJAR, Amar, ASHLEY, David, KELLIE, Stewart, GURURANGAN, Sridharan, HASSALL, Tim, GRONEWOLD, Lindsey, STEWART, Clinton F, WALLACE, Dana, BRONISCER, Alberto

“…To determine the role of amifostine as a protectant against cisplatin-induced ototoxicity in patients with average-risk (AR) medulloblastoma treated with…”
Get full text

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant by Dandoy, Christopher E, Kim, Soyoung, Chen, Min, Ahn, Kwang Woo, Ardura, Monica I, Brown, Valerie, Chhabra, Saurabh, Diaz, Miguel Angel, Dvorak, Christopher, Farhadfar, Nosha, Flagg, Aron, Ganguly, Siddartha, Hale, Gregory A, Hashmi, Shahrukh K, Hematti, Peiman, Martino, Rodrigo, Nishihori, Taiga, Nusrat, Roomi, Olsson, Richard F, Rotz, Seth J, Sung, Anthony D, Perales, Miguel-Angel, Lindemans, Caroline A, Komanduri, Krishna V, Riches, Marcie L

“…Patients undergoing hematopoietic stem cell transplant (HSCT) are at risk for bloodstream infection (BSI) secondary to translocation of bacteria through the…”
Get full text

Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy by TEKAUTZ, Tanya M, FULLER, Christine E, WALLACE, Dana, GILBERTSON, Richard J, GAJJAR, Amar, BLANEY, Susan, FOULADI, Maryam, BRONISCER, Alberto, MERCHANT, Thomas E, KRASIN, Matthew, DALTON, James, HALE, Gregory, KUN, Larry E

“…To describe clinical features, therapeutic approaches, and prognostic factors in pediatric patients with atypical teratoid/rhabdoid tumors (ATRT) treated at St…”
Get full text

Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research by Panepinto, Julie A., Walters, Mark C., Carreras, Jeanette, Marsh, Judith, Bredeson, Christopher N., Gale, Robert Peter, Hale, Gregory A., Horan, John, Hows, Jill M., Klein, John P., Pasquini, Ricardo, Roberts, Irene, Sullivan, Keith, Eapen, Mary, Ferster, Alina

“…Summary We report outcomes after myeloablative haematopoietic cell transplantation (HCT) from human leucocyte antigen (HLA)‐matched sibling donors in 67…”
Get full text